MentionFox
Home › funding signals › Kamal Therapeutics, Inc.
Company · SEC filings

Kamal Therapeutics, Inc. funding history

Before you sign with, sell to or invest in Kamal Therapeutics, Inc.

MentionFox check on Kamal Therapeutics, Inc.: only 2 sources on file so far (checked 17 November 2026). Run a full check before you rely on it. mentionfox.com/c/company/kamal-therapeutics-inc

Check Kamal Therapeutics, Inc. before you sign, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Kamal Therapeutics, Inc.?

Kamal Therapeutics, Inc. has 2 Form D filings on record, from 2022-10-11 to 2025-11-24. Together its new offerings report $13.81M sold.

Is this your company?

Funding historyFounders and team

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

Kamal Therapeutics, Inc.: Raised $13.81M, Form D filed 2025-11-24
Share on LinkedIn Share on X Download image

What do you want to do with Kamal Therapeutics, Inc.?

Is Kamal Therapeutics, Inc. a real, registered company?

Kamal Therapeutics, Inc. is a registered filer with the SEC (CIK 1880064) and has filed since 2022-10-11. 2 filings are on record, the latest on 2025-11-24.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs Kamal Therapeutics, Inc.?

Kamal Therapeutics, Inc.'s filings name Mark de Souza, Alexander Silver, Deborah Ramsdell and 4 more as its officers, directors or promoters.

How much has Kamal Therapeutics, Inc. raised?

Its new offerings report $13.81M sold across 1 offering, as its own filings state.

Run the free check on Kamal Therapeutics, Inc. →

Based
HINGHAM, MASSACHUSETTS
Year formed
2020
Industry group
Pharmaceuticals
Filings
2
Raised (new offerings)
$13.81M

Every filing

FiledTypeAmount soldTotal offeringRecords
2025-11-24New offering
first sale 2025-11-10
$13.81M$17.31Mdetails · SEC filing
2022-10-11Amendment
first sale 2021-08-18
$9.94M$10MSEC filing

Want the whole picture on Kamal Therapeutics, Inc.?

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Kamal Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Kamal Therapeutics, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    2 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.

Every figure here is read from Kamal Therapeutics, Inc.'s own filings with the SEC. The people those filings name are on the team page.

Follow this company

Tools for this story

Each opens in a new tab, filled in for Kamal Therapeutics, Inc.. With no account yet, you sign up free and land on the result.

Cite this page

Permanent URL: https://mentionfox.com/company/kamal-therapeutics-inc
Last updated 2026-11-17
Primary record: SEC filing 1 · SEC filing 2
How much has Kamal Therapeutics, Inc. raised? $13.81M in 2 SEC filings. MentionFox, 2026-11-17. https://mentionfox.com/company/kamal-therapeutics-inc